TheOffer.biz

Welcome,

You have been invited to partner in a business venture. This is a quick synopsis of the problem, the market, product  and the business potential involved.

The Problem:

• 10 Million Americans have Osteoporosis.
• 34 Million Americans have low bone mass.
• 66 Million – joint related issues. TOTAL: 110 Million people affected.
• Studies indicate our teenage youth are at risk for osteoporosis.  Athletes, mothers, older men and women, and anyone seeking a wellness path are candidates.
  • Fosamax sold $3 Billion in 2005.  Boniva sold $417 Million in 2006.
  • Actonel: Proctor & Gamble’s biggest product to reach $1billion in sales.
  • Osteoporosis pharmaceutical market will reach $10.4 billion by 2011.

• “They will not fall and break their bones, they will break their bone…and fall.”

The Current Solution:

• Prescription drugs: designed to inhibit calcium from exiting bones – leaving other bodily systems that require calcium (from bones) to suffer.
• Bones may become denser but are weaker.  Natural bone turnover process is inhibited. Some of the medications may even create a brittle bone matrix.
• Side effects: esophageal cancer, altered taste, mental irritability, numbness, seizures, dental problems (including deteriorating jaw bones), anemia, blood clotting disorders, decreased joint mobility, pain in the muscles, joints and or  bones, eye problems, skin rash, gastrointestinal abnormalities, inflammation of the esophagus, chest pain, heartburn or difficulty swallowing… (and that’s what we’re aware of.)
• Calcium supplementation: Studies indicate, “the excess calcium buries itself in your artery walls and muscle cells where it contributes to high blood pressure and hardening of the arteries. Why do you think doctors give you calcium channel blockers for high blood pressure?” [NewsMax]

A New Breakthrough Technology: OsteoDenx

• Provides a transport system for replenishment of bone… Not a vitamin supplement.
• Not a chemical drug. No negative side effects. Contains no calcium.
• Provides an anti-aging and for some, a reverse-aging effect to the bone.
• Severe osteoporosis cases: double-digit increased bone density is possible in one year.
• Properly functioning bones bring other vital systems into balance.
• Bones (which create red/white blood cells) are fundamental to the immune system.

The Clinical Trials:

• Pre-clinical trial in 2007.  View at www.N-Terminus.com.
• 1^st trial (Osteoporosis International; 2009 Jan 27) shows how Ribonuclease Enriched Lactoferrin (RELF), market name: OsteoDenx, promotes the formation of new capillaries and new bone.
• The 2^nd trial targeting the inflammatory mediators having to do with Osteoarthritis, Rheumatoid Arthritis and Osteopenia. Results TBA early ’09.
• The 3^rd trial showing how RELF effects bone turnover in diabetics. TBA mid ’09.
• The 4^th study showing how RELF effects bone turnover in young adults with obesity.
• The 5^th study showing RELF effects on bone turnover in HIV patients. TBA late ’09.

The Genius: Dr. Narain Naidu, Ph.D.

• His discoveries are the basis for the founding of 4 successful Biotech companies.
• On Faculty of Universities in Europe, Asia and the United States.

• Consults Government Health Agencies, Pharmaceutical and Biotech enterprises worldwide.
• 100 research publications, 25 book chapters, and 2 best selling reference volumes.
• Solved toxic shock syndrome and the e-coli problem in the US beef industry.
• Director: Center for Antimicrobial Research.
• Medical Microbiologist: California State Polytech University.
• Director (Past) www.nterminus.com.
• On the short list for: Nobel Prize.

The Osteodenx Solution:

• Targets the synovial fluid using a Syno-Portin complex unique to Osteodenx,
• Bone metabolism: reestablishes an efficient system as in your youth.
• not a vitamin or mineral supplement – whole new category a Bio-Replenishment
• When our bones function properly other systems can recalibrate.
• 3 Componants: OsteoDenx, Calcium Plus, and  Lactoferrin Gold 1.8.
• exclusive distribution rights.
• Osteodenx technology is protected by 2 patents plus three patents pending.

The Cost Comparison

• One Prescription Actonel pill (150 mg) averages $100 or $400.00+ per month.
• The OsteoDenx Solution: under half the cost and available without a prescription

The Business Potential

With 110 million people (1 out of 3 Americans!) as potential clients who will re-order OsteoDenx each month.  The monthly residual income potential is staggering. Millions of dollars will be made monthly with this product. Do the work one time and it will continue to pay you for years.

We work with a group of local businessmen (Spokane, WA) who have already made millions over the last 15 years introducing cutting edge health technologies from this billion dollar Japanese company .  They are forming teams to market what they believe to be the most lucrative product of its kind to ever hit the US Health market.

If you are a leader and feel you could build a team to market this revolutionary new product, then we invite you to get all the information to make an informed decision. Complete training and support will be provided to all new associates.

This can be done full time or part time along with your current career. It will take a minimum of 11 hours a week part time. One person could never reach the number of people who need this product. Your success does not depend solely on your own sales ability, but on your ability to recruit, train and build a team of associates.

We have a team of experienced and successful mentors to support you each step of the way. Whats the earning potential? That depends on you.  We have people right here in Spokane, WA making 3k, 5k, 10k, 20k, 60k and 100k a month.

To set an appointment to answer questions and explain the venture in full detail please contact the person who sent you to this site or call Rick Moran at 509-994-6199.

Need More information on the OsteoDenx Solution? Please go to the OsteoDenx Overview Page.

What ever you decide to do we wish you all the best!

Sincerely,

Rick Moran